Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 32% ± 20% | |
neuron | 3 studies | 22% ± 6% | |
GABAergic neuron | 3 studies | 44% ± 14% | |
oligodendrocyte | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 6468.46 | 2641 / 2642 | 98% | 33.99 | 690 / 705 |
lung | 91% | 1494.17 | 528 / 578 | 42% | 6.96 | 481 / 1155 |
stomach | 58% | 709.53 | 207 / 359 | 71% | 11.34 | 204 / 286 |
intestine | 46% | 756.57 | 445 / 966 | 63% | 9.42 | 334 / 527 |
uterus | 64% | 724.11 | 108 / 170 | 44% | 9.28 | 203 / 459 |
pancreas | 18% | 131.77 | 58 / 328 | 89% | 20.10 | 159 / 178 |
kidney | 52% | 506.35 | 46 / 89 | 54% | 10.67 | 485 / 901 |
breast | 80% | 1479.18 | 366 / 459 | 23% | 2.87 | 261 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 97% | 37.74 | 28 / 29 |
ovary | 11% | 108.96 | 20 / 180 | 82% | 16.60 | 354 / 430 |
spleen | 93% | 1160.23 | 225 / 241 | 0% | 0 | 0 / 0 |
thymus | 18% | 144.57 | 115 / 653 | 72% | 25.56 | 437 / 605 |
adipose | 89% | 1773.49 | 1071 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 22% | 198.38 | 324 / 1445 | 49% | 8.00 | 90 / 183 |
bladder | 24% | 163.95 | 5 / 21 | 39% | 6.50 | 199 / 504 |
tonsil | 0% | 0 | 0 / 0 | 56% | 25.35 | 25 / 45 |
skin | 26% | 221.52 | 470 / 1809 | 28% | 3.79 | 131 / 472 |
heart | 47% | 458.31 | 404 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 5% | 57.00 | 12 / 258 | 15% | 1.31 | 35 / 230 |
peripheral blood | 19% | 1203.33 | 180 / 929 | 0% | 0 | 0 / 0 |
prostate | 12% | 93.53 | 29 / 245 | 2% | 0.16 | 11 / 502 |
eye | 0% | 0 | 0 / 0 | 14% | 1.12 | 11 / 80 |
blood vessel | 13% | 154.09 | 169 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 3% | 0.70 | 14 / 406 |
muscle | 0% | 3.25 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050890 | Biological process | cognition |
GO_0008104 | Biological process | protein localization |
GO_0006044 | Biological process | N-acetylglucosamine metabolic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0030334 | Biological process | regulation of cell migration |
GO_0050435 | Biological process | amyloid-beta metabolic process |
GO_1902966 | Biological process | positive regulation of protein localization to early endosome |
GO_1905166 | Biological process | negative regulation of lysosomal protein catabolic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0016020 | Cellular component | membrane |
GO_0003830 | Molecular function | beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity |
GO_0016757 | Molecular function | glycosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MGAT3 |
Protein name | Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
Synonyms | GGNT3 |
Description | FUNCTION: It is involved in the regulation of the biosynthesis and biological function of glycoprotein oligosaccharides. Catalyzes the addition of N-acetylglucosamine in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-linked sugar chains, called bisecting N-acetylglucosamine (GlcNAc). It is one of the most important enzymes involved in the regulation of the biosynthesis of glycoprotein oligosaccharides. The addition of this bisecting GlcNAc residue alters not only the composition, but also the conformation of the N-glycan. The introduction of the bisecting GlcNAc residue results in the suppression of further processing and elongation of N-glycans, precluding the formation of beta-1,6 GlcNAc branching, catalyzed by MGAT5 since it is unable to use the bisected oligosaccharide as a substrate . Addition of bisecting N-acetylglucosamine to CDH1/E-cadherin modulates CDH1 cell membrane location . Inhibits NeuAc-alpha-2,3-Gal-beta-1,4-GlcNAc- formation which modulates sialylation levels and plays a role in cell migration regulation . In brain, addition of bisecting N-acetylglucosamine to BACE1 blocks its lysosomal targeting in response to oxidative stress and further degradation which increases its location to early endosome and the APP cleavage (By similarity). . |
Accessions | ENST00000418314.1 ENST00000429402.1 B0QY92 ENST00000341184.7 Q09327 B0QY93 |